Anebulo Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $11.6M | $3.1M | $11.2M | — | — | — |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $12.0M | $3.5M | $11.7M | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $12.1M | $4.1M | $11.7M | $15.6M | $21.7M | $3.0M |
| Liabilities | ||||||
| Accounts Payable | $224.2K | $156.4K | $534.5K | $380.8K | $110.0K | — |
| Total Current Liabilities | — | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $487.7K | $260.6K | $1.1M | $512.5K | $241.6K | $223.9K |
| Stockholders' Equity | ||||||
| Retained Earnings | $-73.9M | $-65.4M | $-57.2M | $-45.5M | $-38.6M | $-183.1K |
| Total Stockholders' Equity | $11.7M | $3.8M | $10.6M | $15.1M | $21.4M | $-171.1K |